In contrast, lymphoid neoplasms with dual MYC and BCL6 rearrangements represent a more diverse spectrum [129] with variable gene expression profiles and mutational spectra, markedly differing from DLBCL/HGBL-MYC/BCL2. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.